Susquehanna raised the firm’s price target on Viavi (VIAV) to $25 from $18 and keeps a Positive rating on the shares. The firm said they increased estimates following 2QFY26 (Dec-Q) results. In short, they think the EPS opportunity has now moved greater thangreater than $1.00, driven by the Spirent asset acquisitions and the inherent organic growth, and this is reflected in their updated FY27 model.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VIAV:
- Viavi price target raised to $28 from $24 at Needham
- Viavi Solutions: Sustained Outperformance, Data Center–Driven Growth, and Cost Efficiencies Support Maintained Buy Rating
- Closing Bell Movers: Meta up 8%, Microsoft down 7% on earnings
- Viavi announces restructuring plan, 5% of global workforce to be affected
- Viavi reports Q2 adjusted EPS 22c, consensus 19c